Durvalumab: Solution concentrate for I.V. infusion 120 mg in 2.4 mL, Solution concentrate for I.V. infusion 500 mg in 10 mL; Imfinzi® Page last updated: 5 March 2021 Public Summary Document (PSD) November 2020 PBAC Meeting - (PDF 1376KB) Public Summary Document (PSD) November 2020 PBAC Meeting - (Word 347KB)